The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma.
TSPO
diagnostic marker
glioblastoma
hallmarks of cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Oct 2020
14 Oct 2020
Historique:
received:
14
09
2020
revised:
09
10
2020
accepted:
09
10
2020
entrez:
17
10
2020
pubmed:
18
10
2020
medline:
18
10
2020
Statut:
epublish
Résumé
Glioblastoma (GBM) is the most fatal primary brain cancer in adults. Despite extensive treatment, tumors inevitably recur, leading to an average survival time shorter than 1.5 years. The 18 kDa translocator protein (TSPO) is abundantly expressed throughout the body including the central nervous system. The expression of TSPO increases in states of inflammation and brain injury due to microglia activation. Not least due to its location in the outer mitochondrial membrane, TSPO has been implicated with a broad spectrum of functions. These include the regulation of proliferation, apoptosis, migration, as well as mitochondrial functions such as mitochondrial respiration and oxidative stress regulation. TSPO is frequently overexpressed in GBM. Its expression level has been positively correlated to WHO grade, glioma cell proliferation, and poor prognosis of patients. Several lines of evidence indicate that TSPO plays a functional part in glioma hallmark features such as resistance to apoptosis, invasiveness, and proliferation. This review provides a critical overview of how TSPO could regulate several aspects of tumorigenesis in GBM, particularly in the context of the hallmarks of cancer proposed by Hanahan and Weinberg in 2011.
Identifiants
pubmed: 33066460
pii: cancers12102973
doi: 10.3390/cancers12102973
pmc: PMC7602186
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 403161218
Références
Curr Pharm Des. 2007;13(23):2385-405
pubmed: 17692008
Cancer Res. 2006 Dec 1;66(23):11502-13
pubmed: 17114236
Int J Mol Sci. 2018 Sep 14;19(9):
pubmed: 30223473
CNS Oncol. 2016;5(2):101-8
pubmed: 26997129
J Biol Chem. 2016 Jan 22;291(4):1591-603
pubmed: 26627829
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3016-3027
pubmed: 28899788
Biochim Biophys Acta. 2008 Feb;1782(2):118-25
pubmed: 18190798
J Alzheimers Dis. 2019;72(4):1045-1058
pubmed: 31256132
Biochem Pharmacol. 2001 Mar 15;61(6):695-705
pubmed: 11266654
Int J Mol Sci. 2020 Jan 17;21(2):
pubmed: 31963507
Nat Rev Drug Discov. 2010 Dec;9(12):971-88
pubmed: 21119734
Cancer Cell. 2016 Feb 8;29(2):201-13
pubmed: 26859459
Cancer Res. 1999 Dec 15;59(24):6091-6
pubmed: 10626796
Life Sci. 2019 Nov 1;236:116917
pubmed: 31614149
Free Radic Biol Med. 2012 Nov 1;53(9):1807-17
pubmed: 22940066
Glia. 2011 Feb;59(2):219-30
pubmed: 21125642
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2547-75
pubmed: 25448878
Mol Cell Biochem. 2008 Jan;307(1-2):141-7
pubmed: 17828582
Neurosurgery. 2002 Jul;51(1):2-12; discussion 12-3
pubmed: 12182418
Neuro Oncol. 1999 Jan;1(1):44-51
pubmed: 11550301
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2421-7
pubmed: 20841389
Mutagenesis. 2004 May;19(3):169-85
pubmed: 15123782
J Psychopharmacol. 2016 May;30(5):474-81
pubmed: 26783231
Int J Mol Sci. 2017 Apr 07;18(4):
pubmed: 28387723
PLoS One. 2013 Aug 14;8(8):e71258
pubmed: 23967175
J Pharmacol Exp Ther. 1990 Nov;255(2):442-50
pubmed: 1978727
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1406-19
pubmed: 23715902
Adv Pharmacol. 2018;82:103-136
pubmed: 29413517
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Acta Neuropathol Commun. 2019 Nov 29;7(1):203
pubmed: 31815646
J Neuroendocrinol. 2020 Jan;32(1):e12796
pubmed: 31536662
J Bioenerg Biomembr. 2008 Jun;40(3):199-205
pubmed: 18670869
Biochemistry (Mosc). 2009 Apr;74(4):421-9
pubmed: 19463096
Pharmacol Ther. 2008 Apr;118(1):1-17
pubmed: 18374421
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Cancer Res. 2004 Oct 1;64(19):6892-9
pubmed: 15466178
Trends Pharmacol Sci. 2006 Aug;27(8):402-9
pubmed: 16822554
Cells. 2019 Oct 28;8(11):
pubmed: 31661894
Cancer Res. 2016 Jan 1;76(1):171-81
pubmed: 26677976
FEBS Lett. 2012 May 7;586(9):1349-55
pubmed: 22616995
J Nucl Med. 2015 Apr;56(4):512-7
pubmed: 25722450
Expert Rev Neurother. 2018 Sep;18(9):729-737
pubmed: 30099909
Biomedicines. 2017 Jun 09;5(2):
pubmed: 28598356
Pharmacol Ther. 2006 Jun;110(3):503-24
pubmed: 16337685
Arch Biochem Biophys. 2015 Dec 1;587:70-7
pubmed: 26498031
F1000Prime Rep. 2014 Mar 03;6:13
pubmed: 24669294
Cancers (Basel). 2014 Feb 10;6(1):376-95
pubmed: 24518612
Oncogene. 2002 Dec 5;21(55):8404-13
pubmed: 12466961
Aging Cell. 2014 Jun;13(3):507-18
pubmed: 24977274
CA Cancer J Clin. 2010 May-Jun;60(3):166-93
pubmed: 20445000
Haematologica. 2007 Dec;92(12):1631-8
pubmed: 18055986
Oncotarget. 2018 Apr 13;9(28):19980-19993
pubmed: 29731997
Mol Imaging Biol. 2018 Feb;20(1):94-102
pubmed: 28695372
Biochem Pharmacol. 1999 Jul 15;58(2):273-8
pubmed: 10423168
Apoptosis. 2015 Mar;20(3):383-98
pubmed: 25413799
Neuro Oncol. 2013 Sep;15(9):1114-26
pubmed: 23877318
Clin Med Oncol. 2009 Apr 8;3:39-52
pubmed: 19777070
J Neurooncol. 2006 Mar;77(1):17-23
pubmed: 16292491
Acta Neuropathol. 2015 Jun;129(6):829-48
pubmed: 25943888
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Immunol Rev. 2012 Mar;246(1):311-26
pubmed: 22435563
Oncotarget. 2017 Apr 4;8(14):23142-23154
pubmed: 28423563
Biochemistry. 2003 Apr 22;42(15):4506-19
pubmed: 12693947
Endocrinology. 1998 Dec;139(12):4991-7
pubmed: 9832438
Mol Cell. 2015 Oct 15;60(2):307-18
pubmed: 26455392
Cancer Res. 2006 Jan 1;66(1):159-67
pubmed: 16397228
J Nucl Med. 2013 Dec;54(12):2125-31
pubmed: 24212976
Cell Cycle. 2017 Mar 4;16(5):436-447
pubmed: 28103132
Biochemistry (Mosc). 2015 Nov;80(11):1393-405
pubmed: 26615431
Biomed Pharmacother. 2020 Jan;121:109588
pubmed: 31707350
Cytokine. 2009 Dec;48(3):161-9
pubmed: 19740675
J Biol Chem. 2014 Apr 11;289(15):10607-19
pubmed: 24599950
J Cereb Blood Flow Metab. 2017 Aug;37(8):2679-2690
pubmed: 28530125
J Med Chem. 2014 Mar 27;57(6):2413-28
pubmed: 24580635
Cancer Lett. 2000 Aug 11;156(2):125-32
pubmed: 10880761
Oncogene. 2005 Nov 17;24(51):7503-13
pubmed: 16091749
Nat Rev Neurosci. 2014 Jul;15(7):455-65
pubmed: 24946761
J Pharmacol Exp Ther. 2007 Oct;323(1):336-45
pubmed: 17640950
Mol Imaging Biol. 2014 Dec;16(6):813-20
pubmed: 24845529
Biochemistry. 2008 Dec 2;47(48):12886-99
pubmed: 18975922
J Neurooncol. 2014 Oct;120(1):73-83
pubmed: 25064688
Biochem Biophys Res Commun. 1999 Nov 19;265(2):457-61
pubmed: 10558889
Curr Mol Med. 2012 May;12(4):494-501
pubmed: 22376065
Pharmacogenet Genomics. 2012 Aug;22(8):606-19
pubmed: 22732722
Biochem Biophys Res Commun. 2004 Nov 12;324(2):878-86
pubmed: 15474510
J Biol Chem. 1994 Dec 9;269(49):31041-6
pubmed: 7983042
Acta Neuropathol. 2013 Jul;126(1):21-37
pubmed: 23689616
World Neurosurg. 2017 Jan;97:279-283
pubmed: 27744078
Cancer Genet Cytogenet. 2002 Nov;139(1):48-51
pubmed: 12547158
Apoptosis. 2012 Jul;17(7):647-65
pubmed: 22544277
Genes Dev. 2005 Sep 15;19(18):2100-10
pubmed: 16166375
Front Biosci (Landmark Ed). 2017 Jun 1;22:1805-1829
pubmed: 28410147
Cell Cycle. 2016 Jul 2;15(13):1755-66
pubmed: 27163626
Clin Immunol. 2009 Jan;130(1):27-33
pubmed: 18845487
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Int J Cancer. 2003 May 10;104(6):752-7
pubmed: 12640683
Eur J Pharmacol. 2007 Apr 10;560(2-3):117-22
pubmed: 17291492
Cell Oncol. 2008;30(5):435-50
pubmed: 18791274
Int Rev Immunol. 2013 Jun;32(3):249-70
pubmed: 23617726
Neuro Oncol. 2016 Feb;18(2):160-72
pubmed: 26180081
Int J Mol Sci. 2019 Sep 10;20(18):
pubmed: 31510070
Cancer Cell. 2018 Jan 8;33(1):152
pubmed: 29316430
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14
pubmed: 23412337
Front Surg. 2016 Mar 02;3:11
pubmed: 26973839
J Neurosci Res. 1991 Nov;30(3):463-74
pubmed: 1666128
J Neuroinflammation. 2014 Jan 08;11:3
pubmed: 24397957
Expert Rev Neurother. 2014 Nov;14(11):1293-306
pubmed: 25262780
Cancers (Basel). 2019 Apr 15;11(4):
pubmed: 30991681
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Genes Dev. 2007 Nov 1;21(21):2683-710
pubmed: 17974913
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Nat Commun. 2014 Nov 19;5:5452
pubmed: 25406832
Am J Pathol. 2009 May;174(5):1588-93
pubmed: 19342369
Acta Pharmacol Sin. 2020 Jan;41(1):34-46
pubmed: 31515530
Apoptosis. 2010 Jul;15(7):753-68
pubmed: 20107899
J Neurochem. 2002 Nov;83(3):546-55
pubmed: 12390516
Neurosurgery. 2019 Oct 1;85(4):524-534
pubmed: 30239840
Biochem Soc Trans. 2015 Aug;43(4):566-71
pubmed: 26551694
Toxicol Res. 2010 Dec;26(4):245-52
pubmed: 24278531
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2256-60
pubmed: 3031675
J Biol Chem. 2014 May 16;289(20):13769-81
pubmed: 24692541
Neurosci Lett. 2004 Sep 30;368(3):279-84
pubmed: 15364411
Neuron Glia Biol. 2011 May;7(2-4):187-97
pubmed: 22874716
Biochim Biophys Acta. 2012 Jan;1819(1):38-56
pubmed: 21958735
Acta Neuropathol. 2017 Jun;133(6):1001-1016
pubmed: 28255664
PLoS One. 2016 Apr 07;11(4):e0152919
pubmed: 27054921
Proc Natl Acad Sci U S A. 1983 Jun;80(11):3531-5
pubmed: 6304714
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Biochem J. 2016 Jan 15;473(2):107-21
pubmed: 26733718
Sci Rep. 2014 Apr 23;4:4749
pubmed: 24756113
J Recept Signal Transduct Res. 2003;23(2-3):225-38
pubmed: 14626449
Cancer Manag Res. 2014 Mar 24;6:149-70
pubmed: 24711712
J Neurosci. 2013 May 15;33(20):8891-7
pubmed: 23678130
Cancer Lett. 2018 Feb 28;415:117-128
pubmed: 29222039
Biochim Biophys Acta. 1995 Jul 17;1241(2):139-76
pubmed: 7640294
Antioxid Redox Signal. 2012 Jun 1;16(11):1323-67
pubmed: 22146081
J Oncol. 2010;2010:351908
pubmed: 20414463
Psychoneuroendocrinology. 2019 Aug;106:65-76
pubmed: 30954920
Biochem Soc Trans. 2015 Aug;43(4):543-52
pubmed: 26551691
Cells. 2020 Feb 24;9(2):
pubmed: 32102369
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2230-2238
pubmed: 28821920
CNS Neurol Disord Drug Targets. 2014;13(4):574-92
pubmed: 24168369
BMC Cancer. 2013 Sep 03;13:402
pubmed: 24004722
Biochemistry. 2005 Jul 26;44(29):9924-35
pubmed: 16026165
J Neuroimmunol. 2018 Sep 15;322:63-73
pubmed: 30049538
Mol Oncol. 2015 Oct;9(8):1612-25
pubmed: 26022108
Prog Lipid Res. 2010 Jul;49(3):218-34
pubmed: 20043945
Curr Pharm Des. 2012;18(10):1319-30
pubmed: 22360558
J Neurochem. 2002 Dec;83(5):1226-34
pubmed: 12437594
Oncogene. 2010 Aug 26;29(34):4741-51
pubmed: 20531305
Semin Cancer Biol. 2015 Dec;35 Suppl:S5-S24
pubmed: 25869442
J Transl Med. 2006 Mar 30;4:15
pubmed: 16573834
Int J Mol Sci. 2019 Jul 08;20(13):
pubmed: 31288390
Tumour Biol. 2015 Feb;36(2):967-72
pubmed: 25315188
Glia. 2009 Jan 1;57(1):79-92
pubmed: 18709649
Mol Cell Endocrinol. 2010 Oct 7;327(1-2):1-12
pubmed: 20600583
Nat Rev Mol Cell Biol. 2020 Feb;21(2):85-100
pubmed: 31636403
Biochem Pharmacol. 2004 Aug 15;68(4):689-98
pubmed: 15276076
Biomed Res Int. 2017;2017:7403747
pubmed: 29259986
Endocrinology. 2018 Feb 1;159(2):1130-1146
pubmed: 29300865
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Cancer Immunol Res. 2013 Aug;1(2):112-22
pubmed: 24409449
Pharmacogenet Genomics. 2008 Nov;18(11):977-88
pubmed: 18806692
Clin Sci (Lond). 2017 Feb 1;131(4):297-308
pubmed: 27923881
Nat Commun. 2013;4:2185
pubmed: 23887589
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Glia. 2020 Feb;68(2):280-297
pubmed: 31479168
Medicine (Baltimore). 2016 Mar;95(9):e2583
pubmed: 26945349
Exp Biol Med (Maywood). 2010 Apr;235(4):478-86
pubmed: 20407080
Br J Cancer. 2001 Nov 30;85(11):1771-80
pubmed: 11742501
Cell Death Dis. 2016 Jun 09;7(6):e2253
pubmed: 27277675
Acta Neuropathol. 2007 Nov;114(5):443-58
pubmed: 17805551
Acta Neuropathol. 2010 Nov;120(5):567-84
pubmed: 20714900
Genes Dev. 2008 Dec 1;22(23):3268-81
pubmed: 19056882
Neuro Oncol. 2020 Feb 20;22(2):240-252
pubmed: 31563962
Nat Neurosci. 2016 Jan;19(1):20-7
pubmed: 26713745
Cell Physiol Biochem. 2006;17(5-6):211-20
pubmed: 16790997
Ann Neurol. 2011 Mar;69(3):455-63
pubmed: 21446021
Mol Neurobiol. 2020 May;57(5):2461-2478
pubmed: 32152825
J Neurooncol. 2007 Jan;81(1):1-7
pubmed: 16868661
Mol Aspects Med. 2010 Jun;31(3):227-85
pubmed: 20346371
Pharmacol Rev. 1999 Dec;51(4):629-50
pubmed: 10581326
J Immunol. 2015 Jul 1;195(1):367-76
pubmed: 26026061
Immunol Invest. 2017 Apr;46(3):263-273
pubmed: 27967259
FEBS J. 2016 Mar;283(5):803-14
pubmed: 26607558
Cancer Res. 2018 Jun 15;78(12):3176-3189
pubmed: 29661831
Mol Med Rep. 2018 Mar;17(3):3951-3959
pubmed: 29328425
Biochemistry. 2010 Jun 15;49(23):4766-78
pubmed: 20469933
Eur J Pharmacol. 2010 Jan 25;626(2-3):131-8
pubmed: 19782064
CNS Neurol Disord Drug Targets. 2017;16(10):1090-1098
pubmed: 29318979
J Bioenerg Biomembr. 2013 Aug;45(4):333-41
pubmed: 23475134
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cancer Res. 2017 Apr 15;77(8):1831-1841
pubmed: 28137769
J Nucl Med. 2016 Feb;57(2):165-8
pubmed: 26697963
Acta Neuropathol. 1997 Sep;94(3):216-25
pubmed: 9292690
Biochem Pharmacol. 2005 Mar 1;69(5):819-30
pubmed: 15710359
J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
pubmed: 22008728
Sci Rep. 2016 Mar 10;6:22811
pubmed: 26960563
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1368-1380
pubmed: 31486876
Cytokine. 2018 Jan;101:14-18
pubmed: 27531077
Front Endocrinol (Lausanne). 2019 Feb 04;10:16
pubmed: 30778332
Autophagy. 2014;10(12):2279-96
pubmed: 25470454
Eur J Med Chem. 2011 Sep;46(9):4506-20
pubmed: 21824692
Cancer Res. 2006 Jun 1;66(11):5618-23
pubmed: 16740698
Int J Mol Sci. 2019 Jul 09;20(13):
pubmed: 31323920
Biochemistry. 2009 Jun 2;48(21):4652-61
pubmed: 19358520
PLoS One. 2017 Oct 2;12(10):e0185767
pubmed: 28968465
Cancer Biol Ther. 2013 Apr;14(4):319-26
pubmed: 23358477
J Cell Biochem. 2008 Oct 15;105(3):712-23
pubmed: 18668527
CNS Oncol. 2013 Jan;2(1):49-65
pubmed: 23750318
Cancer Res. 1995 Jun 15;55(12):2691-5
pubmed: 7780986
Pharmacogenet Genomics. 2012 Jul;22(7):538-50
pubmed: 22547081
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6
pubmed: 23530248
Chem Res Toxicol. 2016 Dec 19;29(12):2008-2039
pubmed: 27989142